Search for: "Sees v. Sees" Results 8201 - 8220 of 121,941
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Dec 2022, 8:10 am by Joel R. Brandes
Since the parties were  unable to reach an agreement on these remaining issues, the court was entitled to fill in the gaps based on objective criteria (see Four Seasons Hotels v. [read post]
23 Dec 2022, 1:16 pm by Jonathan Zasloff
As former White House Chief of Staff John Podesta notes in the WaPo piece, people will see electric cars delivering their mail and think that they are indeed practical, affordable, and reliable. [read post]
23 Dec 2022, 10:00 am by Kelly Goles
On September 14, the Law Library held its annual Constitution Day event, which featured Harvard Law School Professor Mark V. [read post]
23 Dec 2022, 7:08 am by Tian Lu
That is also the case, for example, when that item of evidence is accompanied by other evidence (see, to that effect, judgments of 9 December 2014, Inter-Union Technohandel v OHIM – Gumersport Mediterranea de Distribuciones (PROFLEX), T 278/12, EU:T:2014:1045, paragraphs 64 to 69, and of 7 September 2016, Victor International v EUIPO – Ovejero Jiménez and Becerra Guibert (VICTOR), T 204/14, not published, EU:T:2016:448, paragraph 74).Another interesting… [read post]
23 Dec 2022, 4:33 am by Andrew Lavoott Bluestone
Although “unfounded” allegations are not actionable under Judiciary Law § 487, deliberate misrepresentations are (see Amalfitano v Rosenberg, 12 NY3d 8, 11-15 [2009]; Ticketmaster Corp. v Lidsky, 245 AD2d 142, 143 [1st Dept 1997]; Redmond v Bailey, 2012 NY Slip Op 31081[U], *6 [Sup Ct, Queens County 2012]). [read post]
23 Dec 2022, 4:00 am by Elaine Hou
As you can see, our most prolific author was none other than our very own Chris Walker! [read post]
23 Dec 2022, 12:14 am by Frank Cranmer
I do not see how it could have been otherwise. [read post]
22 Dec 2022, 3:15 pm by Lawrence B. Ebert
’s (collectively, “Sandoz’s”) generic product would not induce infringement of the LFT patents, and (3) sale of Sandoz’s generic product would not directly infringe Genentech’s Drug-Drug Interaction (“DDI”) patents.2 See Genentech, Inc. v. [read post]